EMD Research, page-18

I see you are involved in the 4 medicinal cannabis ZLD, IHL, EMD and BOT. Would love to hear your take on which one has the highest chances of success.

from my research I would order them:

1- ZLD, 2 TGA approved products in OZ and US. By the end of 2021, 10 approved products In UK , Germany, US and OZ
Cons: near term stock dilution from US

2- IHL, generates cash from CBD oil sales Circa 600k, possible FDA approvals, stock price passed the 10c and maintained above

3- EMD, it generates income from data sales, data is key to getting approvals, targeting TGA. Only 225 M shares, management owns 60%

4- BOT, it is at the bottom of the list giving it’s disappointing trial result few months ago resulting in the SP to fall 50% in one day.


they are targeting FDA approval though